The Medical Device Business Journal — Medical Device News & Articles | MassDevice
Impending federal excise taxes, downward pricing pressure and declining volumes of big-ticket procedures constitute a triple threat that will drive the medical device industry to consolidate, according to a PricewaterhouseCoopers report.
The total value of health care deals over the past 12 months rose 40 percent, according to the consulting giant’s “U.S. Mid-Year M&A Outlook.” That trend is likely to continue, the report predicts.
Medical device firms fetched $602 million in venture funding during the first quarter of 2011, up 8 percent from the same period last year and good for the best first quarter the industry has had in three years, according to a new Money Tree report.
The Money Tree report, conducted by PricewaterhouseCoopers using data provided by Thomson Reuters, said investors closed 79 investments in medical device companies at all stages during the quarter, up 11 percent from the 71 deals done during the same period last year.
A new report found that health care reform is accelerating the collaboration between physicians and hospitals.
The report challenges the traditional notion that physicians are independent from and not financially tied to hospitals.
Venture capital investing appears to be improving in Minnesota, according to an In Private venture report compiled from documents filed with the U.S. Securities & Exchange Commission.
The report shows that Minnesota firms raised a total of $51 million during the first quarter. This is up from about $30 million in 2010’s fourth quarter, based on the MoneyTree Report by PricewaterhouseCoopers and the National Capital Association, using data from Thomson Reuters.
Venture capitalists once again pulled back on investments into biomedical companies in California during 2010, even more so than during the height of the recession, according to a new study released today.
The report titled, “California Biomedical Industry Annual Report,” was produced by California Healthcare Institute, BayBio and PricewaterhouseCoopers.
PricewaterhouseCoopers, Moneytree, and the BioEnterprise delivered bad news for the medical device community this week: Investment has slipped, the United States’ dominance is eroding, and nimbleness in emerging markets poses a long-term threat to United States as the leader in developing new innovative medical devices.
Marching orders are clear and unsurprising. We need more innovation, talent, financial incentives, investment, and sleeker and faster regulation. The question is, even if can do all or most of these things well, will it be enough to compete with the speed of growth in countries like China, India and Brazil?
The U.S. is quickly losing ground to emerging markets in medical technology innovation, according to a new study from PricewaterhouseCoopers.
"The nature of innovation is changing as developing nations become the leading markets for smaller, faster, more affordable devices that enable delivery of care anywhere and help bend the cost curve downward," PwC wrote in its latest Medical Technology Innovation Scorecard.
